SiRNA depletion of BRCA1, but not BRCA2, causes increased genome instability in Fanconi anemia cells

被引:43
|
作者
Bruun, D [1 ]
Folias, A [1 ]
Akkari, Y [1 ]
Cox, Y [1 ]
Olson, S [1 ]
Moses, R [1 ]
机构
[1] Oregon Hlth Sci Univ, Dept Mol & Med Genet, Portland, OR 97201 USA
关键词
siRNA; BRCA; 1; BRCA2; Fanconi anemia;
D O I
10.1016/S1568-7864(03)00112-5
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
BRCA1 and BRCA2 proteins act in repair of interstrand crosslinks (ICLs) and maintenance of genome stability and are known to be part of the Fanconi anemia (FA) pathway. We have investigated the role of the BRCA1 and BRCA2 genes in genome stability following ICL damage in normal and FA cells. To circumvent cell lethality of complete disruptions in BRCA1 or BRCA2, small inhibitory RNA (siRNA) was used to transiently deplete the expression of the proteins. Using chromosomal stability after ICL damage as the end point, we find that BRCA1 functions in more than just the FA pathway for genome maintenance, whereas BRCA2 appears to act predominantly in the FA pathway. Depletion of BRCA1 causes a marked decrease, although not a complete absence Of, ubiquitination of FANCD2. In contrast to BRCA1, BRCA2 is not needed for normal ubiquitination of FANCD2 after DNA damage, a requirement for the FA pathway to function. Thus, BRCA2 is epistatic to FA genes for ICL repair, but not for damage-induced modification of FANCD2 and may act downstream form FANCD2. (C) 2003 Elsevier B.V All rights reserved.
引用
收藏
页码:1007 / 1013
页数:7
相关论文
共 50 条
  • [21] Ectopic expression of BRCA1 Corrects Fanconi Anemia Pathway and Chromosomal Instability in CML cells
    Valeri, A.
    Alonso-Ferrero, M. E.
    Rio, P.
    Pujol, M. R.
    Casado, J. A.
    Perez, L.
    Jacome, A.
    Agirre, X.
    Calasanz, M. J.
    Hanenberg, H.
    Surralles, J.
    Prosper, F.
    Albella, B.
    Bueren, J. A.
    HUMAN GENE THERAPY, 2010, 21 (10) : 1365 - 1365
  • [22] Surveillance of BRCA1 and BRCA2 carriers
    Helvie, M
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (08): : 931 - 931
  • [23] BRCA1 and BRCA2: to test or not to test
    Brandt, RT
    Lynch, HT
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 67 (02) : 187 - 188
  • [24] BRCA1 and BRCA2 in breast cancer
    Lee, WH
    Boyer, TG
    LANCET, 2001, : S5 - S5
  • [25] Functional assays for BRCA1 and BRCA2
    Carvalho, Marcelo A.
    Couch, Fergus J.
    Monteiro, Alvaro N. A.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (02): : 298 - 310
  • [26] A model of the BRCA1/BRCA2 network
    MA Pujana
    J-DJ Han
    LM Starita
    M Tewari
    JS Ahn
    V Assmann
    WM ElShamy
    J-F Rual
    R Gelman
    K Gunsalus
    R Greenberg
    B Bohian
    N Bertin
    N Ayivi-Guedehoussou
    KL Nathanson
    BL Weber
    DE Hill
    DM Livingston
    JD Parvin
    M Vidal
    Breast Cancer Research, 7
  • [27] Insights into the functions of BRCA1 and BRCA2
    Welcsh, PL
    Owens, KN
    King, MC
    TRENDS IN GENETICS, 2000, 16 (02) : 69 - 74
  • [28] BRCA1 and BRCA2: 1994 and beyond
    Steven A. Narod
    William D. Foulkes
    Nature Reviews Cancer, 2004, 4 : 665 - 676
  • [29] BRCA1 and BRCA2 in breast cancer
    Xiaohong Yang
    Marc E. Lippman
    Breast Cancer Research and Treatment, 1999, 54 : 1 - 10
  • [30] Are Endometrial Cancers Arising in BRCA1/BRCA2 Germline Mutations Carriers True BRCA1/BRCA2 Cancers?
    Paula, Arnaud Da Cruz
    Smith, Evan
    Cadoo, Karen
    Abu-Rustum, Nadeem
    Pei, Xin
    Riaz, Nadeem
    Robson, Mark
    Reis-Filho, Jorge
    Mandelker, Diana
    Weigelt, Britta
    MODERN PATHOLOGY, 2019, 32